Kamada Ltd is a biopharmaceutical company that specializes in the development and commercialization of innovative therapeutics for rare and serious diseases. The company focuses on producing protein-based drugs, particularly in the fields of immunology and respiratory medicine, utilizing its proprietary technology platforms. By developing therapies that address unmet medical needs, Kamada aims to improve the quality of life for patients while advancing healthcare solutions in specialized treatment areas. The company actively engages in partnerships and collaborations to enhance its research and development efforts, striving to bring new and effective treatments to market. Read More
NEW YORK CITY, NY / ACCESS Newswire / March 18, 2025 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day March Small-Cap Conference taking place Wednesday and Thursday, March 19-20, 2025. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.
Shares of Kamada Ltd. (NASDAQ: KMDA) traded at a new 52-week high today and are currently trading at $5.29. So far today, approximately 287.54k shares have been exchanged, as compared to an average 30-day volume of 20,106 shares.
Gainers ParaZero Technologies Ltd. (NASDAQ: PRZO) shares jumped 106% to $2.3901 after the company announced an Australian regulator approved first commercial drone flights in populated areas and near people using ParaZero safety systems.
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.
Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares jumped 209.1% to $0.5622 after the United States Patent and Trademark Office granted the company a patent for certain medical systems and methods.
Companies Reporting Before The Bell • Bank of Nova Scotia (NYSE:BNS) is estimated to report quarterly earnings at $1.78 per share on revenue of $8.09 billion.
